MENU

PROMOGRAN PRISMA™ Matrix Dressing


PROMOGRAN PRISMA™ Matrix Dressing
PROMOGRAN PRISMA™ Matrix Dressing

A Clinically Proven Combination

PROMOGRAN PRISMA™ Matrix is comprised of a sterile, freeze dried composite of 44% oxidized regenerated cellulose (ORC), 55% collagen and 1% silver-ORC. Silver-ORC contains 25 % w/w ionically bound silver, a well-known antimicrobial agent.
Optimum wound environment
PROMOGRAN PRISMA™ Matrix maintains a physiologically moist microenvironment at the wound surface. This environment is conducive to granulation tissue formation, epithelization and optimal wound healing. Ionically-bound silver is an antimicrobial agent.
 
Clinically Proven
The efficacy of PROMOGRAN PRISMA™ Matrix is supported by a body of clinical evidence, including 1 published RCT1.
 

How it Works

  • About
  • Materials For Download

About

Maintains an optimum wound-healing environment

In the presence of exudate, PROMOGRAN PRISMA™ Matrix transforms into a soft, conformable, biodegradable gel, allowing contact with all areas of the wound.
 
PROMOGRAN PRISMA™ Matrix maintains a physiologically moist microenvironment at the wound surface. This environment is conducive to granulation tissue formation, epithelialization and optimal wound healing.
 
  • Optimum wound environment
  • Clinically proven

Indications & Applications

Indications & Applications

Indications for Use

PROMOGRAN PRISMA™ Matrix is intended for the management of exuding wounds.
 
Under the supervision of a health care professional, PROMOGRAN PRISMA™ Matrix
may be used for the management of:
 
  • Diabetic ulcers
  • Venous ulcers
  • Pressure ulcers
  • Ulcers caused by mixed vascular etiologies
  • Full-thickness and partial thickness wounds
  • Donor sites and other bleeding surface wounds
  • Abrasions
  • Traumatic wounds healing by secondary intention
  • Dehisced surgical wounds
 
Please refer to the full instructions for use in the packaging insert
 

Usage Videos

Evidence & Outcomes

The efficacy of PROMOGRAN PRISMA Matrix is supported by clinical evidence, including a published RCT.
 

Clinical Evidence

Additional summary of evidence and outcomes.

Evidence & Outcomes

Supporting Publications

Title Study Type Date Authors
Can natural materials be adapted to optimize their efficiency in wound care?
In vitro
2014
Gibson M et al.
A randomized controlled trial on collagen/oxidized regenerated cellulose / silver vs best standard of care.
Level one RCT study
2013
Gottrup, et al.
Managing the wound environment using collagen/ORC/ silver dressing
Clinical / in vitro
2010
Cullen et al.
An in vitro model to evaluate the ability of collagen/ORC/silver to absorb components of wound exudate and reduce inflammatory protease activity compared with other dressings.
In vitro
2011
Gibson et al.
In vitro and clinical data demonstrating the ability of collagen/PRD/silver to overcome the hostile chronic wound environment.
In vitro
2010
Cullen et al.
A retrospective study of sequential therapy with advanced wound care products versus saline gauze dressings: Comparing healing and cost.
2010
Snyder et al.
Clinical experiences derived from implementation of an easy to use concept for treatment of wound healing by secondary intention and guidance in selection of appropriate dressings
2011
Braumann et al.
Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review
2013
Holmes et al.
A pilot randomised trial to determine the effects of a new active dressing on wound healing of venous leg ulcers
2008
Lanzara et al.
A retrospective study of sequential therapy with advanced wound care products versus saline gauze dressings: comparing healing and cost
2010
Snyder et al.

Ordering Information

Product Codes

Product Item Code Eaches/Carton/Box/HCPCS Code
PROMOGRAN PRISMA™ Matrix
4.34 sq.in Hexagon
MA028
10 eaches/CT 4 CT/BX/A6021
PROMOGRAN PRISMA™ Matrix
19.1 sq.in Hexagon
MA123
10 eaches/CT 4 CT/BX/A6022
Want to learn more? Please call 1-800-275-4524 or click here.

Related Products

Footer Navigation